ARTICLE | Distillery Therapeutics
Hepatic
February 20, 2019 4:13 PM UTC
Mouse studies suggest INSIG1 could help treat non-alcoholic fatty liver disease (NAFLD). In a AMPK-knockout mouse model of NAFLD, INSIG1 encoded in an adenoviral vector decreased liver triglyceride le...
BCIQ Company Profiles